Determining the impact of alternative splicing events on transcriptome dynamics

BMC Research Notes

Volumn 1, Issue , 2008, Pages

  Wilhelm, Emmanuelle ^a   Pellay, François Xavier ^b   Benecke, Arndt ^b   Bell, Brendan ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349732740     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-1-94     Document Type: Article

References (19)

1. Initial sequencing and analysis of the human genome. ES Lander LM Linton B Birren C Nusbaum MC Zody J Baldwin K Devon K Dewar M Doyle W FitzHugh, et al. Nature 2001 409 6822 860 921 10.1038/35057062 11237011
2. The sequence of the human genome. JC Venter MD Adams EW Myers PW Li RJ Mural GG Sutton HO Smith M Yandell CA Evans RA Holt, et al. Science 2001 291 5507 1304 1351 10.1126/science.1058040 11181995
3. A genomic view of alternative splicing. B Modrek C Lee, Nat Genet 2002 30 1 13 19 10.1038/ng0102-13 11753382
4. Mechanisms of Alternative Pre-Messenger RNA Splicing. DL Black, Annu Rev Biochem 2003 12626338
5. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. JM Johnson J Castle P Garrett-Engele Z Kan PM Loerch CD Armour R Santos EE Schadt R Stoughton DD Shoemaker, Science 2003 302 5653 2141 2144 10.1126/science.1090100 14684825
6. Alternative splicing in disease and therapy. MA Garcia-Blanco AP Baraniak EL Lasda, Nat Biotechnol 2004 22 5 535 546 10.1038/nbt964 15122293
7. Are splicing mutations the most frequent cause of hereditary disease? N Lopez-Bigas B Audit C Ouzounis G Parra R Guigo, FEBS Lett 2005 579 9 1900 1903 10.1016/j.febslet.2005.02.047 15792793
8. Splicing in disease: disruption of the splicing code and the decoding machinery. GS Wang TA Cooper, Nat Rev Genet 2007 8 10 749 761 10.1038/nrg2164 17726481
9. RNA modulation, repair and remodeling by splice switching oligonucleotides. R Kole T Williams L Cohen, Acta Biochim Pol 2004 51 2 373 378 15218534
10. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. LH Boise M Gonzalez-Garcia CE Postema L Ding T Lindsten LA Turka X Mao G Nunez CB Thompson, Cell 1993 74 4 597 608 10.1016/0092-8674(93) 90508-N 8358789
11. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. JK Taylor QQ Zhang JR Wyatt NM Dean, Nat Biotechnol 1999 17 11 1097 1100 10.1038/15079 10545916
12. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. DR Mercatante CD Bortner JA Cidlowski R Kole, J Biol Chem 2001 276 19 16411 16417 10.1074/jbc.M009256200 11278482
13. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. DR Mercatante JL Mohler R Kole, J Biol Chem 2002 277 51 49374 49382 10.1074/jbc.M209236200 12381725
14. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. P Sazani SH Kang MA Maier C Wei J Dillman J Summerton M Manoharan R Kole, Nucleic Acids Res 2001 29 19 3965 3974 11574678
15. High-sensitivity transcriptome data structure and implications for analysis and biologic interpretation. S Noth G Brysbaert FX Pellay A Benecke, Genomics Proteomics Bioinformatics 2006 4 4 212 229 10.1016/S1672-0229(07)60002- 3 17531797
16. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. Y Wang C Barbacioru F Hyland W Xiao KL Hunkapiller J Blake F Chan C Gonzalez L Zhang RR Samaha, BMC Genomics 2006 7 59 16551369 10.1186/1471-2164-7-59
17. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. DR Mercatante R Kole, Biochim Biophys Acta 2002 1587 2-3 126 132 12084454
18. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains. L Lindenboim C Borner R Stein, Cell Death Differ 2001 8 9 933 942 10.1038/sj.cdd.4400888 11526448
19. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism. K Boon-Unge Q Yu T Zou A Zhou P Govitrapong J Zhou, Chem Biol 2007 14 12 1386 1392 10.1016/j.chembiol.2007.11.004 18096507